Compare IMSR & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMSR | ANGO |
|---|---|---|
| Founded | 2013 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 400.4M | 420.2M |
| IPO Year | 2024 | 2004 |
| Metric | IMSR | ANGO |
|---|---|---|
| Price | $2.87 | $12.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $11.67 | ★ $19.75 |
| AVG Volume (30 Days) | ★ 1.4M | 989.6K |
| Earning Date | 11-10-2026 | 10-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $248,357.00 | ★ $291,010,000.00 |
| Revenue This Year | N/A | $5.47 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $2.79 | $9.39 |
| 52 Week High | $16.38 | $16.29 |
| Indicator | IMSR | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 32.54 | 36.62 |
| Support Level | N/A | $11.96 |
| Resistance Level | $5.69 | $12.53 |
| Average True Range (ATR) | 0.26 | 0.83 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 9.19 | 27.01 |
Terrestrial Energy Inc develops Generation IV nuclear power plants based on its proprietary Integral Molten Salt Reactor (IMSR) technology. Its small modular reactor plants are designed to provide low-carbon electricity and high-temperature industrial heat for applications including power generation, petrochemical and chemical processing, and data centers. The company is working with regulators, suppliers, industrial partners, and energy users to develop, license, and commission IMSR plants.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.